Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...

Add Yahoo as a preferred source to see more of our stories on Google. Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...

Arteries are blood vessels that carry blood away from your heart. Pulmonary arterial hypertension (PAH) is a condition where you have high blood pressure in the arteries that go from your heart to ...

Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...

In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...

Please provide your email address to receive an email when new articles are posted on . In patients with pulmonary arterial hypertension, many initially receive just one drug of the combination ...

HONOLULU -- Are the updated European guidelines on pulmonary arterial hypertension (PAH) applicable to American practice? The European Society of Cardiology and European Respiratory Society guidelines ...

Pulmonary hypertension is characterized by increased BP in the pulmonary vasculature You will want your patients to consult a specialist to slow progression of this debilitating disease. Here's what ...